Src Inhibits the Hippo Tumor Suppressor Pathway through Tyrosine Phosphorylation of Lats1
Published version of a preprint
The DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.
Abstract
The Hippo pathway regulates cell proliferation, apoptosis, and stem cell self-renewal, and its inactivation in animal models causes organ enlargement followed by tumorigenesis. Hippo pathway deregulation occurs in many human cancers, but the underlying mechanisms are not fully understood. Here, we report tyrosine phosphorylation of the Hippo pathway tumor suppressor LATS1 as a mechanism underlying its regulation by cell adhesion. A tyrosine kinase library screen identified Src as the kinase to directly phosphorylate LATS1 on multiple residues, causing attenuated Mob kinase activator binding and structural alteration of the substrate-binding pocket in the kinase domain. Cell matrix adhesion activated the Hippo pathway effector transcription coactivator YAP partially through Src-mediated phosphorylation and inhibition of LATS1. Aberrant Src activation abolished the tumor suppressor activity of LATS1 and induced tumorigenesis in a YAP-dependent manner. Protein levels of Src in human breast cancer tissues correlated with accumulation of active YAP dephosphorylated on the LATS1 target site. These findings reveal tyrosine phosphorylation of LATS1 by Src as a novel mechanism of Hippo pathway regulation by cell adhesion and suggest Src activation as an underlying reason for YAP deregulation in tumorigenesis. Cancer Res; 77(18); 4868–80. ©2017 AACR.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Role of YAP/TAZ in mechanotransduction
Dupont, S., Morsut, L., Aragona, M., Enzo, E., Giulitti, S., Cordenonsi, M., Zanconato, F., Le Digabel, J., Forcato, M., Bicciato, S., et al. (2011) · Nature · doi:10.1038/nature10137 · Cited by 5,979 · cited 1×
“For example, YAP is regulated by cell–cell adhesion, cell–matrix adhesion, matrix stiffness and geometry, shear flow and stretch (4, 26, 35, 36).”
Zhao, B., Wei, X., Li, W., Udan, R. S., Yang, Q., Kim, J., Xie, J., Ikenoue, T., Yu, J., Li, L., et al. (2007) · Genes & Development · doi:10.1101/gad.1602907 · Cited by 3,092 · cited 3×
“However, how PDK1 regulates Lats activity is unclear and in our experimental conditions inhibition of PI3K or genetic knockout of PDK1 does not affect YAP phosphorylation (4).”
Self-citationTEAD mediates YAP-dependent gene induction and growth control
Zhao, B., Ye, X., Yu, J., Li, L., Li, W., Li, S., Yu, J., Lin, J. D., Wang, C.-Y., Chinnaiyan, A. M., et al. (2008) · Genes & Development · doi:10.1101/gad.1664408 · Cited by 2,498
Self-citationHippo pathway in organ size control, tissue homeostasis, and cancer
Yu, F.-X., Zhao, B., & Guan, K.-L. (2015) · Cell · doi:10.1016/j.cell.2015.10.044 · Cited by 2,206
Self-citationRegulation of the Hippo-YAP Pathway by G-Protein-Coupled Receptor Signaling
Yu, F.-X., Zhao, B., Panupinthu, N., Jewell, J. L., Lian, I., Wang, L. H., Zhao, J., Yuan, H., Tumaneng, K., Li, H., et al. (2012) · Cell · doi:10.1016/j.cell.2012.06.037 · Cited by 1,628
Self-citationCalvo, F., Ege, N., Grande-Garcia, A., Hooper, S., Jenkins, R. P., Chaudhry, S. I., Harrington, K., Williamson, P., Moeendarbary, E., Charras, G., et al. (2013) · Nature Cell Biology · doi:10.1038/ncb2756 · Cited by 1,478
A coordinated phosphorylation by Lats and CK1 regulates YAP stability through SCF β-TRCP
Zhao, B., Li, L., Tumaneng, K., Wang, C.-Y., & Guan, K.-L. (2010) · Genes & Development · doi:10.1101/gad.1843810 · Cited by 1,418 · cited 1×
“Phosphorylation by Lats inactivates YAP and TAZ through cytoplasmic retention and protein degradation (4-9).”
Self-citationYAP1 increases organ size and expands undifferentiated progenitor cells
Camargo, F. D., Gokhale, S., Johnnidis, J. B., Fu, D., Bell, G. W., Jaenisch, R., & Brummelkamp, T. R. (2007) · Current Biology · doi:10.1016/j.cub.2007.10.039 · Cited by 1,252 · cited 1×
“Nevertheless, the potent tumorigenic activity of YAP has been demonstrated in various animal models (18-21).”
Identification and validation of oncogenes in liver cancer using an integrative oncogenomic approach
Zender, L., Spector, M. S., Xue, W., Flemming, P., Cordon-Cardo, C., Silke, J., Fan, S.-T., Luk, J. M., Wigler, M., Hannon, G. J., et al. (2006) · Cell · doi:10.1016/j.cell.2006.05.030 · Cited by 1,065
Yap1 acts downstream of α-catenin to control epidermal proliferation
Schlegelmilch, K., Mohseni, M., Kirak, O., Pruszak, J., Rodriguez, J. R., Zhou, D., Kreger, B. T., Vasioukhin, V., Avruch, J., Brummelkamp, T. R., et al. (2011) · Cell · doi:10.1016/j.cell.2011.02.031 · Cited by 1,036
Research works printed but not linked: 33
- Pan, 2010, The hippo signaling pathway in development and cancer, Dev Cell, 19, 491, 10.1016/j.devcel.2010.09.011 · DOI · Paper page
- Lai, 2005, Control of cell proliferation and apoptosis by mob as tumor suppressor, mats, Cell, 120, 675, 10.1016/j.cell.2004.12.036 · DOI · Paper page
- Hao, 2008, Tumor suppressor LATS1 is a negative regulator of oncogene YAP, J Biol Chem, 283, 5496, 10.1074/jbc.M709037200 · DOI · Paper page
- Lei, 2008, TAZ promotes cell proliferation and epithelial-mesenchymal transition and is inhibited by the hippo pathway, Mol Cell Biol, 28, 2426, 10.1128/MCB.01874-07 · DOI · Paper page
- Oka, 2008, Mst2 and Lats kinases regulate apoptotic function of Yes kinase-associated protein (YAP), J Biol Chem, 283, 27534, 10.1074/jbc.M804380200 · DOI · Paper page
- Feng, 2014, Hippo-independent activation of YAP by the GNAQ uveal melanoma oncogene through a trio-regulated rho GTPase signaling circuitry, Cancer Cell, 25, 831, 10.1016/j.ccr.2014.04.016 · DOI · Paper page
- Yu, 2014, Mutant Gq/11 promote uveal melanoma tumorigenesis by activating YAP, Cancer Cell, 25, 822, 10.1016/j.ccr.2014.04.017 · DOI · Paper page
- Song, 2014, Identification of genomic alterations in oesophageal squamous cell cancer, Nature, 509, 91, 10.1038/nature13176 · DOI · Paper page
- Fernandez, 2009, YAP1 is amplified and up-regulated in hedgehog-associated medulloblastomas and mediates Sonic hedgehog-driven neural precursor proliferation, Genes Dev, 23, 2729, 10.1101/gad.1824509 · DOI · Paper page
- Overholtzer, 2006, Transforming properties of YAP, a candidate oncogene on the chromosome 11q22 amplicon, Proc Natl Acad Sci U S A, 103, 12405, 10.1073/pnas.0605579103 · DOI · Paper page
- Dong, 2007, Elucidation of a universal size-control mechanism in Drosophila and mammals, Cell, 130, 1120, 10.1016/j.cell.2007.07.019 · DOI · Paper page
- Shen, 2015, A miR-130a-YAP positive feedback loop promotes organ size and tumorigenesis, Cell research, 25, 997, 10.1038/cr.2015.98 · DOI · Paper page
- Schroeder, 2012, Regulation of the Hippo pathway by cell architecture and mechanical signals, Semin Cell Dev Biol, 23, 803, 10.1016/j.semcdb.2012.06.001 · DOI
- Zhao, 2012, Cell detachment activates the Hippo pathway via cytoskeleton reorganization to induce anoikis, Genes Dev, 26, 54, 10.1101/gad.173435.111 · DOI · Paper page
- Kaplan, 1995, c-Src enhances the spreading of src-/- fibroblasts on fibronectin by a kinase-independent mechanism, Genes Dev, 9, 1505, 10.1101/gad.9.12.1505 · DOI · Paper page
- Cooper, 1986, Tyr527 is phosphorylated in pp60c-src: implications for regulation, Science, 231, 1431, 10.1126/science.2420005 · DOI · Paper page
- Lippa, 2008, Synthesis and structure based optimization of novel Akt inhibitors, Bioorg Med Chem Lett, 18, 3359, 10.1016/j.bmcl.2008.04.034 · doi:10.1016/j.bmcl.2008.04.034
- Kim, 2015, Adhesion to fibronectin regulates Hippo signaling via the FAK-Src-PI3K pathway, J Cell Biol, 210, 503, 10.1083/jcb.201501025 · DOI · Paper page
- Brown, 1996, Regulation, substrates and functions of src, Biochim Biophys Acta, 1287, 121
- Zhao, 2009, Both TEAD-binding and WW domains are required for the growth stimulation and oncogenic transformation activity of yes-associated protein, Cancer Res, 69, 1089, 10.1158/0008-5472.CAN-08-2997 · DOI · Paper page
- Dehm, 2004, SRC gene expression in human cancer: the role of transcriptional activation, Biochem Cell Biol, 82, 263, 10.1139/o03-077 · DOI · Paper page
- Codelia, 2014, Regulation of YAP by mechanical strain through Jnk and Hippo signaling, Curr Biol, 24, 2012, 10.1016/j.cub.2014.07.034 · DOI · Paper page
- Paszek, 2005, Tensional homeostasis and the malignant phenotype, Cancer Cell, 8, 241, 10.1016/j.ccr.2005.08.010 · DOI · Paper page
- Deng, 2015, Spectrin regulates Hippo signaling by modulating cortical actomyosin activity, eLife, 4, e06567, 10.7554/eLife.06567 · DOI · Paper page
- Fletcher, 2015, The Spectrin cytoskeleton regulates the Hippo signalling pathway, EMBO J, 34, 940, 10.15252/embj.201489642 · DOI · Paper page
- Kono, 2014, Inhibition of RHO-ROCK signaling enhances ICM and suppresses TE characteristics through activation of Hippo signaling in the mouse blastocyst, Dev Biol, 394, 142, 10.1016/j.ydbio.2014.06.023 · DOI · Paper page
- Yin, 2013, Spatial organization of Hippo signaling at the plasma membrane mediated by the tumor suppressor Merlin/NF2, Cell, 154, 1342, 10.1016/j.cell.2013.08.025 · DOI · Paper page
- Rauskolb, 2014, Cytoskeletal tension inhibits Hippo signaling through an Ajuba-Warts complex, Cell, 158, 143, 10.1016/j.cell.2014.05.035 · DOI · Paper page
- Sudol, 1994, Yes-associated protein (YAP65) is a proline-rich phosphoprotein that binds to the SH3 domain of the Yes proto-oncogene product, Oncogene, 9, 2145
- Zaidi, 2004, Tyrosine phosphorylation controls Runx2-mediated subnuclear targeting of YAP to repress transcription, EMBO J, 23, 790, 10.1038/sj.emboj.7600073 · DOI · Paper page
- Zhang, 2012, Targeting Src family kinases in anti-cancer therapies: turning promise into triumph, Trends Pharmacol Sci, 33, 122, 10.1016/j.tips.2011.11.002 · DOI · Paper page
- Zhao, 2015, The Hippo pathway in chemotherapeutic drug resistance, Int J Cancer, 137, 2767, 10.1002/ijc.29293 · DOI · Paper page
- Moroishi, 2015, The emerging roles of YAP and TAZ in cancer, Nat Rev Cancer, 15, 73, 10.1038/nrc3876 · DOI · Paper page
Cited by
Every step of the way: integrins in cancer progression and metastasis
Hamidi, H., & Ivaska, J. (2018) · Nature Reviews Cancer · doi:10.1038/s41568-018-0038-z · Cited by 1,493
The Hippo Pathway: Biology and Pathophysiology
Ma, S., Meng, Z., Chen, R., & Guan, K.-L. (2019) · Annual Review of Biochemistry · doi:10.1146/annurev-biochem-013118-111829 · Cited by 1,387
“Notably, in addition to phosphorylation by MST1/2 and MAP4Ks, tyrosine phosphorylation by SRC leads to LATS1/2 inactivation (159).”
BackgroundCooper, J., & Giancotti, F. G. (2019) · Cancer Cell · doi:10.1016/j.ccell.2019.01.007 · Cited by 945
The Hippo Signaling Network and Its Biological Functions
Misra, J. R., & Irvine, K. D. (2018) · Annual Review of Genetics · doi:10.1146/annurev-genet-120417-031621 · Cited by 497
Control of cellular responses to mechanical cues through YAP/TAZ regulation
Dasgupta, I., & McCollum, D. (2019) · Journal of Biological Chemistry · doi:10.1074/jbc.rev119.007963 · Cited by 360
Metadata
- Authors
- Si, Y., Ji, X., Cao, X., Dai, X., Xu, L., Zhao, H., Guo, X., Yan, H., Zhang, H., Zhu, C., Zhou, Q., Tang, M., Xia, Z., Li, L., Cong, Y.-S., Ye, S., Liang, T., Feng, X.-H., & Zhao, B.
- Venue
- Cancer Research
- Published
- 2017-09-14
- Volume
- 77
- Issue
- 18
- Pages
- 4868-4880
- ISSN
- 0008-5472 (ISSN-L)
- 1538-7445
- OpenAlex
- W2741967371
- Cited by
- 144
- References
- 17
- FWCI
- 7.73
- Type
- journal article
- Language
- en
- Open access
- closed
- Funders
- National Natural Science Foundation of China (31471316 and 31422036, 31661130150, 31525001)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Src Inhibits the Hippo Tumor Suppressor Pathway through Tyrosine Phosphorylation of Lats1. https://app.cochat.ai/papers/10.1158/0008-5472.can-17-0391
- The paper
- Si, Y., Ji, X., Cao, X., Dai, X., Xu, L., Zhao, H., Guo, X., Yan, H., Zhang, H., Zhu, C., Zhou, Q., Tang, M., Xia, Z., Li, L., Cong, Y.-S., Ye, S., Liang, T., Feng, X.-H., & Zhao, B. (2017). Src Inhibits the Hippo Tumor Suppressor Pathway through Tyrosine Phosphorylation of Lats1. Cancer Research. https://doi.org/10.1158/0008-5472.can-17-0391
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.